Performance of various criteria sets in patients with inflammatory back pain of short duration;: the Maastricht early spondyloarthritis clinic

被引:64
作者
Heuft-Dorenbosch, L.
Landewe, R.
Weijers, R.
Houben, H.
van der Linden, S.
Jacobs, P.
van der Heijde, D.
机构
[1] Univ Hosp Maastricht, Div Rheumatol, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands
[2] Laurentius Hosp, Roermond, Netherlands
[3] Atrium Med Ctr, Dept Rheumatol, Heerlen, Netherlands
[4] Univ Hosp Maastricht, Dept Radiol, NL-6202 AZ Maastricht, Netherlands
关键词
D O I
10.1136/ard.2006.053918
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To describe how patients presenting with inflammatory back pain (IBP) of short duration can be classified by different sets of classification criteria for spondyloarthritis (SpA) and ankylosing spondylitis, and which clinical and imaging features are of discernible importance. Methods: 68 patients with IBP of a maximum of 2 years' duration were included in the early spondyloarthritis cohort. Detailed history, clinical examination and imaging of sacroiliac joints by plain radiography and magnetic resonance imaging (MRI) were obtained. The Berlin criteria set for SpA that has a prominent place for MRI and human leucocyte antigen B27 was used to quantify the relative contribution of MRI in classifying SpA. Results: 14 of the 68 patients had ankylosing spondylitis according to the modified New York criteria, 57 patients fulfilled the European Spondylarthropathy Study Group (ESSG) criteria for SpA, 48 patients fulfilled the Amor criteria for SpA (43 patients fulfilled both criteria sets) and 44 patients fulfilled the Berlin criteria for SpA. Only four patients did not fulfil any criteria set; 36 patients fulfilled ESSG, Amor and Berlin criteria. The 14 patients with ankylosing spondylitis fulfilled all three SpA criteria sets. Conclusion: Among our selected cohort of patients with early IBP, the prevalence of SpA according to three different criteria sets is high. The ESSG criteria were the most sensitive, followed by the Amor criteria and the Berlin criteria. The modified New York criteria for ankylosing spondylitis appeared to be the most specific. In this cohort, the contribution of MRI and human leucocyte antigen B27 to purely clinical criteria in making a diagnosis of axial SpA was limited.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 18 条
[1]  
AMOR B, 1990, REV RHUM, V57, P85
[2]   Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging:: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences [J].
Baraliakos, X ;
Hermann, KGA ;
Landewé, R ;
Listing, J ;
Golder, W ;
Brandt, J ;
Rudwaleit, M ;
Bollow, M ;
Sieper, J ;
van der Heijde, D ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1141-1144
[3]   EARLY SACROILIITIS IN PATIENTS WITH SPONDYLOARTHROPATHY - EVALUATION WITH DYNAMIC GADOLINIUM-ENHANCED MR-IMAGING [J].
BOLLOW, M ;
BRAUN, J ;
HAMM, B ;
EGGENS, U ;
SCHILLING, A ;
KONIG, H ;
WOLF, KJ .
RADIOLOGY, 1995, 194 (02) :529-536
[4]   CLINICAL HISTORY AS A SCREENING-TEST FOR ANKYLOSING-SPONDYLITIS [J].
CALIN, A ;
PORTA, J ;
FRIES, JF ;
SCHURMAN, DJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (24) :2613-2614
[5]  
CALIN A, 1994, J RHEUMATOL, V21, P2281
[6]   THE EUROPEAN-SPONDYLARTHROPATHY-STUDY-GROUP PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SPONDYLARTHROPATHY [J].
DOUGADOS, M ;
VANDERLINDEN, S ;
JUHLIN, R ;
HUITFELDT, B ;
AMOR, B ;
CALIN, A ;
CATS, A ;
DIJKMANS, B ;
OLIVIERI, I ;
PASERO, G ;
VEYS, E ;
ZEIDLER, H .
ARTHRITIS AND RHEUMATISM, 1991, 34 (10) :1218-1227
[7]   Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis [J].
Doward, LC ;
Spoorenberg, A ;
Cook, SA ;
Whalley, D ;
Helliwell, PS ;
Kay, LJ ;
McKenna, SP ;
Tennant, A ;
van der Heijde, D ;
Chamberlain, MA .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (01) :20-26
[8]   Scientific contributions of ankylosing spondylitis patient advocacy groups [J].
Feldtkeller, E ;
Bruckel, J ;
Khan, MA .
CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (04) :239-247
[9]  
GARRETT S, 1994, J RHEUMATOL, V21, P2286
[10]  
HANLY JG, 1994, J RHEUMATOL, V21, P2088